ArticleslgStudy

biology

Stallergenes Greer

Stallergenes Greer is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Stallergenes Greer rather than just read about it. In short: Stallergenes Greer International AG is a Swiss biopharmaceutical company specializing in the field of allergen immunotherapy. Headquartered in Baar, Switzerland, Stallergenes Greer International AG is the parent company of Greer Laboratories, Inc.

Key takeaways

  • Stallergenes Greer belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Stallergenes Greer to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Stallergenes Greer from memory before moving on to harder problems.

Reference excerpt

Stallergenes Greer International AG is a Swiss biopharmaceutical company specializing in the field of allergen immunotherapy. Headquartered in Baar, Switzerland, Stallergenes Greer International AG is the parent company of Greer Laboratories, Inc. (registered office in the U.S.) and Stallergenes S.A.S. (registered office in France). With 1200 employees in 2026, Stallergenes Greer has a global presence 45 countries through its subsidiaries, manufacturing sites and distribution network. Stallergenes Greer's core manufacturing facilities are located both in Europe (Antony and Amilly in France), the United States (Lenoir, North Carolina; Mathiston, Mississippi; and San Diego), and Canada (Dutton, Ontario).

History Stallergenes was founded in 1962 by Institut Mérieux In 2015, Stallergenes and Greer Laboratories Inc. merged to form Stallergenes Greer. Greer was founded by R.T. Greer, a collector of source materials (i.e.: roots, herbs, pollens) in 1904. Stallergenes Greer is a privately held company owned by B-Flexion (ex Waypoint Capital), chaired by Ernesto Bertarelli.

Products Stallergenes Greer specialises in allergy immunotherapy treatments. It includes name patient products which are allergen products prepared in accordance with physician written prescriptions for individual patients. The commercial product portfolio consists of sublingual products (Staloral, Oralair, Actair), subcutaneous products (Alustal/Albey), oral formulations (Palforzia), custom ordered bulk allergen extracts, veterinary products, and general laboratory consumables such as sterilized glass vials.

Governance The board of directors includes:

Dr Andreas Amrein, Chairman of the Board and Chief Executive Officer Nithya Desikan Steven Rotman Frédéric Boder

Pharmaceutical and clinical development programme

Since 2003, Stallergenes has been involved in a clinical development programme whose objective is to develop proprietary medicines intended to cover the main allergens responsible for more than 80% of respiratory allergies. Oralair is the first sublingual allergen immunotherapy tablet resulting from this programme. Oralair is marketed in 22 countries and has been approved by the Food and Drug Administration in the United States. The second project in this programme is the house dust mite allergen derived product Actair which is marketed in Japan, Australia, and New Zealand, and South Korea under the brand name Actair and in Europe under the brand names Orylmyte or Aitmyte. In 2021, Stallergenes Greer is partnering with Aptar Pharma to develop a novel connected device for allergen immunotherapy purposes. In 2022, Stallergenes Greer conducted the EfficAPSI study, comparing 330,000 patients treated with standard antihistamines and corticosteroids to approximately 110,000 patients receiving allergen immunotherapy. The results were published in 2024 in The Lancet Regional Health Europe, which describes it as one of the largest real-world studies based on French national health data. In 2023, the group added Palforzia, an oral product for peanut allergy, to its portfolio, thereby expanding into the field of food allergy. In 2025, Stallergenes Greer completed a phase III clinical trial of a sublingual allergen immunotherapy treatment in children and adolescents suffering from birch pollen allergy.

References

External links Official website

Worked examples

Example 1 — a first encounter with Stallergenes Greer

Start with the simplest possible case. Write down what Stallergenes Greer claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Stallergenes Greer before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Stallergenes Greer ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Stallergenes Greer

In research
Stallergenes Greer appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Stallergenes Greer in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Stallergenes Greer is common in secondary-school and first-year university syllabi. It links to neighbouring topics Allergology, Companies based in the canton of Zug, Pharmaceutical companies of Switzerland, so understanding it makes those chapters shorter.
In everyday life
Look for Stallergenes Greer outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Stallergenes Greer” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Stallergenes Greer in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Stallergenes Greer means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Stallergenes Greer out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Stallergenes Greer in simple terms?

Stallergenes Greer International AG is a Swiss biopharmaceutical company specializing in the field of allergen immunotherapy. Headquartered in Baar, Switzerland, Stallergenes Greer International AG is the parent company of Greer Laboratories, Inc.

Why does Stallergenes Greer matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Stallergenes Greer?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Stallergenes Greer.

Tags

  • Allergology
  • Companies based in the canton of Zug
  • Pharmaceutical companies of Switzerland
  • Swiss companies established in 2015

Keep exploring